Drug Type ASO |
Synonyms- |
Target |
Action modulators |
Mechanism KEAP1 modulators(Kelch-like ECH-associated protein 1 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Amyotrophic Lateral Sclerosis | Preclinical | United States | 04 Nov 2018 | |
| Amyotrophic Lateral Sclerosis | Preclinical | United States | 04 Nov 2018 | |
| Retinal Degeneration | Preclinical | United States | 04 Nov 2018 | |
| Retinal Degeneration | Preclinical | United States | 04 Nov 2018 |





